E Choi

4.9k total citations · 1 hit paper
24 papers, 3.8k citations indexed

About

E Choi is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, E Choi has authored 24 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in E Choi's work include T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). E Choi is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). E Choi collaborates with scholars based in United States, United Kingdom and Tanzania. E Choi's co-authors include Joyce McCann, Edna N. Yamasaki, B N Ames, Vincenzo Cerundolo, P. Rod Dunbar, Ji‐Li Chen, Linda Wooldridge, Michael J. Palmowski, Andrew K. Sewell and Bent K. Jakobsen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

E Choi

24 papers receiving 3.4k citations

Hit Papers

Detection of carcinogens as mutagens in the Salmonella/mi... 1975 2026 1992 2009 1975 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Choi United States 18 1.8k 1.5k 781 679 622 24 3.8k
Werner K. Lutz Switzerland 40 2.0k 1.1× 1.8k 1.2× 1.1k 1.4× 414 0.6× 832 1.3× 157 5.0k
Kim L. O’Neill United States 33 1.2k 0.6× 1.7k 1.1× 609 0.8× 356 0.5× 546 0.9× 129 4.4k
Sheila M. Galloway United States 38 3.0k 1.6× 2.4k 1.6× 1.2k 1.5× 204 0.3× 1.2k 2.0× 97 5.3k
Nigel J. Gooderham United Kingdom 37 1.7k 0.9× 1.9k 1.2× 552 0.7× 263 0.4× 391 0.6× 165 4.2k
Bas J. Blaauboer Netherlands 37 661 0.4× 1.3k 0.9× 1.4k 1.8× 220 0.3× 373 0.6× 134 4.6k
Gordon C. Hard United States 37 1.1k 0.6× 1.3k 0.9× 456 0.6× 306 0.5× 483 0.8× 134 3.8k
Marilyn J. Aardema United States 40 2.6k 1.4× 1.8k 1.2× 1.6k 2.1× 157 0.2× 1.1k 1.8× 98 5.0k
Raymond W. Tennant United States 39 2.6k 1.4× 2.7k 1.8× 1.4k 1.8× 462 0.7× 698 1.1× 159 6.5k
L S Gold United States 23 1.5k 0.8× 1.2k 0.8× 876 1.1× 128 0.2× 426 0.7× 27 3.6k
Robert H. Heflich United States 45 3.4k 1.9× 3.4k 2.2× 1.6k 2.0× 236 0.3× 1.0k 1.6× 246 6.9k

Countries citing papers authored by E Choi

Since Specialization
Citations

This map shows the geographic impact of E Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Choi more than expected).

Fields of papers citing papers by E Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Choi. The network helps show where E Choi may publish in the future.

Co-authorship network of co-authors of E Choi

This figure shows the co-authorship network connecting the top 25 collaborators of E Choi. A scholar is included among the top collaborators of E Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Choi. E Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Watson‐Jones, Deborah, Hugo Kavunga‐Membo, Rebecca F. Grais, et al.. (2022). Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo. BMJ Open. 12(3). e055596–e055596. 13 indexed citations
3.
Choi, E. (2021). COVID-19 vaccines for low- and middle-income countries. Transactions of the Royal Society of Tropical Medicine and Hygiene. 115(5). 447–456. 47 indexed citations
4.
Choi, E, Daniel K. W. Chu, Peter K.C. Cheng, et al.. (2020). In-Flight Transmission of SARS-CoV-2. Emerging infectious diseases. 26(11). 2713–2716. 58 indexed citations
5.
Majumdar, Amitabha, Huoqing Jiang, Mohammed Repon Khan, et al.. (2012). Critical Role of Amyloid-like Oligomers of Drosophila Orb2 in the Persistence of Memory. Cell. 148(3). 515–529. 214 indexed citations
6.
Choi, E, Michael D. Geschwind, Camille Deering, et al.. (2009). Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt–Jakob disease. Laboratory Investigation. 89(6). 624–635. 21 indexed citations
7.
Chen, Ji‐Li, Guillaume Stewart-Jones, Giovanna Bossi, et al.. (2005). Structural and kinetic basis for heightened immunogenicity of T cell vaccines. The Journal of Experimental Medicine. 201(8). 1243–1255. 215 indexed citations
8.
Choi, E, Ji‐Li Chen, Linda Wooldridge, et al.. (2003). High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining. The Journal of Immunology. 171(10). 5116–5123. 75 indexed citations
10.
Palmowski, Michael J., E Choi, Ian F. Hermans, et al.. (2002). Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols. The Journal of Immunology. 168(9). 4391–4398. 135 indexed citations
11.
Choi, E, et al.. (2002). The use of chimeric A2Kb tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice. Journal of Immunological Methods. 268(1). 35–41. 20 indexed citations
12.
Luyrink, Lorie, Susan D. Thompson, Alexei A. Grom, et al.. (1993). Reduced expression of a human V beta 6.1 T-cell receptor allele.. Proceedings of the National Academy of Sciences. 90(10). 4369–4373. 40 indexed citations
13.
Kerckhove, Catherine Van, Lorie Luyrink, Joby Taylor, et al.. (1991). HLA-DQA1*0101 haplotypes and disease outcome in early onset pauciarticular juvenile rheumatoid arthritis.. PubMed. 18(6). 874–9. 19 indexed citations
14.
Welch, Thomas R., Linda Beischel, E Choi, Kamala Balakrishnan, & Nancy A. Bishof. (1990). Uniparental isodisomy 6 associated with deficiency of the fourth component of complement.. Journal of Clinical Investigation. 86(2). 675–678. 57 indexed citations
15.
Lee, Janet, Silvia Sartoris, Paola Briata, et al.. (1989). Sequence polymorphism of HLA-DP beta chains. Immunogenetics. 29(5). 346–349. 19 indexed citations
16.
Choi, E, et al.. (1989). An intronic 10-base-pair deletion in a class II A beta gene affects RNA processing.. Molecular and Cellular Biology. 9(10). 4402–4408. 4 indexed citations
17.
Griffith, I J, E Choi, & Laurie H. Glimcher. (1987). A single base mutation in an I-A alpha-chain gene alters T-cell recognition.. Proceedings of the National Academy of Sciences. 84(4). 1090–1093. 16 indexed citations
18.
Cohn, Lauren, Laurie H. Glimcher, Rainer Waldmann, et al.. (1986). Identification of functional regions on the I-Ab molecule by site-directed mutagenesis.. Proceedings of the National Academy of Sciences. 83(3). 747–751. 38 indexed citations
19.
Ben‐Nun, Avraham, E Choi, Katherine McIntyre, et al.. (1985). DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.. The Journal of Immunology. 135(2). 1456–1464. 36 indexed citations
20.
Seidman, Christine E., Kenneth D. Bloch, John A. Smith, et al.. (1985). Molecular studies of the atrial natriuretic factor gene.. Hypertension. 7(3_pt_2). I31–4. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026